![](/img/cover-not-exists.png)
Design and Discovery of N-(3-(2-(2-hydroxyethoxy)-6-morpholinopyridin-4-yl)-4-methylphenyl)-2-(trifluoromethyl)isonicotinamide (LXH254)- A selective, efficacious and well-tolerated RAF inhibitor targeting RAS mutant cancers: The path to the clinic
Ramurthy, Savithri, Taft, Benjamin Robert, Aversa, Robert J., Barsanti, Paul, Burger, Matthew T, Lou, Yan, Nishiguchi, Gisele, Rico, Alice, Setti, Lina, Smith, Aaron, Subramanian, Sharadha, Tamez, VicLanguage:
english
Journal:
Journal of Medicinal Chemistry
DOI:
10.1021/acs.jmedchem.9b00161
Date:
May, 2019
File:
PDF, 1.47 MB
english, 2019